This is seen in the case of the seminoma cell line, TCAM2 (Selfe et al., 2018), which despite comparatively high basal levels of activated IGF1R among TGCT cell lines was among the least responsive to an IGF1R TKI. The gene discussed is IGF1R; the disease is seminoma.